Discovery of thiophen-2-ylmethylene bis-dimedone derivatives as novel WRN inhibitors for treating cancers with microsatellite instability

Hwasun Yang, Miso Kang, Seonyeong Jang, Soo Yeon Baek, Jiwon Kim, Gyeong Un Kim, Dongwoo Kim, Junsu Ha, Jong Seung Kim, Cheulhee Jung, Nam Jung Kim, Sung Yup Cho, Woong Hee Shin, Juyong Lee, Junsu Ko, Ansoo Lee, Gyochang Keum, Sanghee Lee, Taek Kang

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Abstract

Microsatellite instability (MSI) is a hypermutable condition caused by DNA mismatch repair system defects, contributing to the development of various cancer types. Recent research has identified Werner syndrome ATP-dependent helicase (WRN) as a promising synthetic lethal target for MSI cancers. Herein, we report the first discovery of thiophen-2-ylmethylene bis-dimedone derivatives as novel WRN inhibitors for MSI cancer therapy. Initial computational analysis and biological evaluation identified a new scaffold for a WRN inhibitor. Subsequent SAR study led to the discovery of a highly potent WRN inhibitor. Furthermore, we demonstrated that the optimal compound induced DNA damage and apoptotic cell death in MSI cancer cells by inhibiting WRN. This study provides a new pharmacophore for WRN inhibitors, emphasizing their therapeutic potential for MSI cancers.

Original languageEnglish
Article number117588
JournalBioorganic and Medicinal Chemistry
Volume100
DOIs
Publication statusPublished - 15 Feb 2024

Bibliographical note

Publisher Copyright:
© 2024 Elsevier Ltd

Keywords

  • Anticancer
  • Microsatellite instability
  • Synthetic lethality
  • Thiophene
  • WRN inhibitor
  • bis-Dimedone

Fingerprint

Dive into the research topics of 'Discovery of thiophen-2-ylmethylene bis-dimedone derivatives as novel WRN inhibitors for treating cancers with microsatellite instability'. Together they form a unique fingerprint.

Cite this